NI
BMY icon

Nepsis Inc’s Bristol-Myers Squibb BMY Stock Holding History

Nepsis Inc’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$16.2M Buy
259,326
+816
+0.3% +$51.6K 5.1% 6
2026
Q2 		$14.9M Sell
258,510
-3,672
-1% -$211K 5.05% 8
2026
Q1 		$15.9M Sell
262,182
-11,967
-4% -$698K 5.33% 7
2025
Q4 		$14.8M Buy
274,149
+90,852
+50% +$4.37M 4.57% 11
2025
Q3 		$8.27M Sell
183,297
-30,221
-14% -$1.41M 2.62% 21
2025
Q2 		$9.88M Sell
213,518
-11,288
-5% -$554K 2.75% 22
2025
Q1 		$13.7M Buy
+224,806
New +$13.1M 3.39% 18
2024
Q4 		– Sell
-70,768
Closed -$3.66M – 28
2024
Q3 		$3.66M Buy
70,768
+65,078
+1,144% +$3.05M 0.87% 26
2024
Q2 		$236K Sell
5,690
-230,591
-98% -$10.3M 0.06% 28
2024
Q1 		$12.8M Buy
236,281
+30,099
+15% +$1.53M 3.47% 17
2023
Q4 		$10.6M Sell
206,182
-31,894
-13% -$1.67M 3.01% 19
2023
Q3 		$13.8M Buy
238,076
+30,192
+15% +$1.85M 4.23% 15
2023
Q2 		$13.3M Buy
207,884
+3,270
+2% +$219K 4.1% 12
2023
Q1 		$14.2M Buy
204,614
+20,492
+11% +$1.45M 4.72% 9
2022
Q4 		$13.2M Buy
184,122
+4,943
+3% +$373K 4.44% 8
2022
Q3 		$12.7M Sell
179,179
-2,373
-1% -$172K 4.6% 9
2022
Q2 		$14M Buy
181,552
+8,459
+5% +$644K 4.77% 7
2022
Q1 		$12.6M Sell
173,093
-76,724
-31% -$5.15M 3.77% 17
2021
Q4 		$15.6M Buy
249,817
+32,465
+15% +$1.9M 4.52% 9
2021
Q3 		$12.9M Buy
217,352
+33,324
+18% +$2.19M 4.05% 13
2021
Q2 		$12.3M Sell
184,028
-2,790
-1% -$182K 3.9% 13
2021
Q1 		$11.8M Buy
186,818
+41,815
+29% +$2.6M 3.73% 13
2020
Q4 		$8.99M Buy
145,003
+6,997
+5% +$430K 3.27% 14
2020
Q3 		$8.32M Buy
138,006
+22,833
+20% +$1.37M 3.99% 9
2020
Q2 		$6.77M Buy
+115,173
New +$6.89M 3.28% 16

Other funds holding BMY

Artemis Investment Management
Artemis Investment Management Edinburgh, United Kingdom $11.5B AUM 61.77% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $67.3B AUM 21.9% 1-Year Est. Return
Douglas Lane & Associates
Douglas Lane & Associates New York $7.46B AUM 24.36% 1-Year Est. Return
MN Services Vermogensbeheer
MN Services Vermogensbeheer The Hague, Netherlands $13.4B AUM 37.34% 1-Year Est. Return
Czech National Bank
Czech National Bank Prague, Czech Republic $18.9B AUM 36.24% 1-Year Est. Return
IFM Investors
IFM Investors Melbourne, Australia $16B AUM 33.69% 1-Year Est. Return
Wedge Capital Management
Wedge Capital Management Charlotte, North Carolina $5.72B AUM 38.26% 1-Year Est. Return
VFM
Viking Fund Management Minot, North Dakota $1.14B AUM 32.65% 1-Year Est. Return
NAM
NorthCrest Asset Manangement Plymouth, Minnesota $4.24B AUM 32.82% 1-Year Est. Return
Avanza Fonder
Avanza Fonder Stockholm, Sweden $5.23B AUM 33.79% 1-Year Est. Return

Nepsis Inc's BMY Position: Q3 2026 in Review

Nepsis Inc increased its Bristol-Myers Squibb (BMY) stake by 0.32% in Q3 2026, buying an estimated $51.6K and bringing the position to 259,326 shares worth $16.2M. The position accounts for 5.1% of the portfolio, ranked #6.

Nepsis Inc first reported a position in BMY in Q2 2020 and has held it in 25 quarters since. 276 funds tracked by Wall St. Rank hold BMY as of Q3 2026.

  • Nepsis Inc held 259,326 shares of Bristol-Myers Squibb worth $16.2M as of Q3 2026.
  • Nepsis Inc bought 816 Bristol-Myers Squibb shares in Q3 2026, an estimated $51.6K.
  • Bristol-Myers Squibb made up 5.1% of Nepsis Inc's portfolio in Q3 2026, its #6 holding.
  • Nepsis Inc first reported a position in Bristol-Myers Squibb in Q2 2020 and has held it in 25 quarters since.
  • 276 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2026.

Based on Nepsis Inc's 13F filing for Q3 2026, filed 13 Oct 2026.